Advances in heart and lung transplantation 2004: Report from the 24th International Society for Heart and Lung Transplantation Annual Meeting, San Francisco, April 21–24, 2004
- 31 August 2004
- journal article
- editorial
- Published by Elsevier BV in The Journal of Heart and Lung Transplantation
- Vol. 23 (8), 925-930
- https://doi.org/10.1016/j.healun.2004.05.002
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Cardiac allograft vasculopathy after heart transplantation: risk factors and managementThe Journal of Heart and Lung Transplantation, 2004
- Favorable effect of Everolimus on cardiac allograft vasculopathy is maintained through 24 monthsThe Journal of Heart and Lung Transplantation, 2004
- Further analysis of the intravascular ultrasound data from the randomized mycophenolate mofetil (MMF) trial in heart transplant recipientsThe Journal of Heart and Lung Transplantation, 2004
- Sirolimus from the time of heart transplantation - persistent protection from graft vasculopathy at 2 yearsThe Journal of Heart and Lung Transplantation, 2004
- Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant RecipientsNew England Journal of Medicine, 2003
- First-year intravascular ultrasound results as a surrogate marker for outcomes after heart transplantationThe Journal of Heart and Lung Transplantation, 2003
- TOR inhibitors and cardiac allograft vasculopathy: is inhibition of intimal thickening an adequate surrogate of benefit?The Journal of Heart and Lung Transplantation, 2003
- Intravascular ultrasound imaging after cardiac transplantation: advantage of multi-vessel imagingThe Journal of Heart and Lung Transplantation, 2000
- A RANDOMIZED ACTIVE-CONTROLLED TRIAL OF MYCOPHENOLATE MOFETIL IN HEART TRANSPLANT RECIPIENTS1Transplantation, 1998
- Prognostic Importance of Intimal Thickness as Measured by Intracoronary Ultrasound After Cardiac TransplantationCirculation, 1995